Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 37 min ago
Peer-reviewedCC BY 4.0Nature Chemical Biology

Structures of human telomerase with BIBR1532 reveal novel mechanism of inhibition

  1. 1Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA USA
  2. 2Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA USA

Abstract

Human telomerase processively adds telomeric repeats (dGGTTAG) to chromosome 3′-ends to maintain telomere length. While mostly absent in somatic cells, telomerase is aberrantly upregulated in most tumor cells to sustain cellular immortality, making it a promising oncology target. However, to date there are no reported structures of human telomerase with inhibitor, impeding structure-based drug design and optimization. We report nine cryo-electron microscopy structures of human telomerase with and without BIBR1532, a highly selective small-molecule telomerase inhibitor. Unexpectedly, BIBR1532 binds a previously unknown pocket between TERT finger and palm. BIBR1532 inhibits each step but disproportionately affects the rate-limiting first step of telomere repeat nucleotide addition. The structures reveal a rigid finger that explains telomerase’s slow rate and low fidelity. Our study provides insights into telomerase catalytic mechanism and its inhibition by BIBR1532, explains why prior BIBR derivatives did not improve potency and suggests a rational approach for design of small-molecule telomerase inhibitors.

Related

  1. Cell-state-dependent responses to PLK1 inhibition reveal a non-canonical microtubule-endolysosomal vulnerability in quiescent leukemia stem cells
    Q. Liu, M. Gojsevic, A. Varesi +18
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Small-molecule ACOD1 inhibition attenuates colitis and tumor growth through a shared myeloid mechanism, diverging from genetic deletion
    A. E. Papathanassiu, W. Li, K. Gilbo +1
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  3. Volatile flavoromics and metabolomics reveal quality evolution mechanism of Zhenghe white peony tea during storage
    Wenlong Li, Yashu Wei, Wenmiao Wu +5
    NPJ Science of FoodPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  4. Study on the molecular mechanism of chlorotoxin from Buthus martensii Karsch in the inhibition of glioma angiogenesis
    Yiming Wang, Yaning Zhao, Ziyang Ren +3
    PLOS OnePeer-reviewedCC BYFull textCell biologyDevelopmental biologyPLOSEurope PMCPMC
  5. Structure of PCPE-2 in complex with the BMP-1 metalloprotease reveals the molecular basis of its mechanism of inhibition
    Julien Bauer, Priscillia Lagoutte, Jonathan Vaneyck +6
    HALPreprintCC BY 4.0Full textOncologyHALbioRxiv
BibTeX
@article{wang2026structures,
  title = {{Structures of human telomerase with BIBR1532 reveal novel mechanism of inhibition}},
  author = {Yuqing Wang and Baocheng Liu and Yao He and Juli Feigon},
  journal = {Nature Chemical Biology},
  year = {2026},
  month = jun,
  doi = {10.1038/s41589-026-02238-6},
  url = {https://doi.org/10.1038/s41589-026-02238-6},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Structures of human telomerase with BIBR1532 reveal novel mechanism of inhibition
AU  - Yuqing Wang
AU  - Baocheng Liu
AU  - Yao He
AU  - Juli Feigon
PY  - 2026
DA  - 2026/06/02
JO  - Nature Chemical Biology
DO  - 10.1038/s41589-026-02238-6
UR  - https://doi.org/10.1038/s41589-026-02238-6
AB  - Human telomerase processively adds telomeric repeats (dGGTTAG) to chromosome 3′-ends to maintain telomere length. While mostly absent in somatic cells, telomerase is aberrantly upregulated in most tumor cells to sustain cellular immortality, making it a promising oncology target. However, to date there are no reported structures of human telomerase with inhibitor, impeding structure-based drug design and optimization. We report nine cryo-electron microscopy structures of human telomerase with and without BIBR1532, a highly selective small-molecule telomerase inhibitor. Unexpectedly, BIBR1532 binds a previously unknown pocket between TERT finger and palm. BIBR1532 inhibits each step but disproportionately affects the rate-limiting first step of telomere repeat nucleotide addition. The structures reveal a rigid finger that explains telomerase’s slow rate and low fidelity. Our study provides insights into telomerase catalytic mechanism and its inhibition by BIBR1532, explains why prior BIBR derivatives did not improve potency and suggests a rational approach for design of small-molecule telomerase inhibitors.
SN  - 1552-4450
SN  - 1552-4469
ER  -